Resources for Researchers & Startups

COVID-19 technology?

Our online portal is open and ready.
Disclose now

We have seen our inventors and entrepreneurs rise to the challenges brought by COVID-19 this past year, and we are thankful and proud of each one of you. We at UF Innovate are here to facilitate your efforts as you continue to invent, create entrepreneurial solutions, and do all you can to change the world for the better. We hope this page of resources and stories about how UF Innovate research and entrepreneurs are doing their part to help in this pandemic encourages and inspires you.

Contact us.

Apply Here

illustration of money

Small business owners can apply for a First Draw Loan from the Payroll Protection Program by the U.S. Small Business Administration. Applications still open.

Grants & Funding

image of the coronavirus, COVID-19

Looking for program development and funding opportunities during COVID-19? Visit UF’s Emerging Pathogen’s Funding webpage to learn about available grants.

Latest UF Research

two beakers depicting research

UF researchers continue to respond to the COVID-19 crisis by doing what they do best — finding answers and solutions. Read the latest research here.

Loan Guidelines

flag of the United States of America

The U.S. Chamber of Commerce continues to help companies stay afloat and keep paychecks flowing and more. Details on relief package and vaccines here.

CORD-19 Dataset

Help generate new insights to fight COVID-19, collaborate with other researchers worldwide, participate in the CORD-19 Challenge. Learn more.

UF Health Facts

Get the fast facts about UF Health’s responses and learn about the work our researchers conduct to combat the global pandemic. The latest here.

Startup Advice

logo for Osage University Partners, a venture capital firmDo you have an idea for a startup? OUP’s tech and life sciences teams are offering free VC office hours to UF researchers. Sign up for a 30-minute complimentary session.

Funding Innovation

illustration of a microscope

The Bill & Melinda Gates Foundation pledges millions to fund innovation that tackles COVID-19 challenges. Get the latest here.

Impact on Research

logo for University of Florida Research

The coronavirus is a challenge impacting researchers at the university. UF Research is doing its best to keep researchers updated. More here.

UF Innovate Tech & Startups Aid the Fight

UF Health Expert Discusses COVID-19 Booster Shots

Michael Lauzardo, M.D., deputy director of UF’s Emerging Pathogens Institute and an associate professor in the UF College of Medicine’s department of medicine, talks about issues related to the third vaccine dose. 

Oragenics’ SARS-CoV-2 Spike Protein Produces Neutralizing Antibodies in Mice With Intramuscular and Intranasal Adjuvants

UF startup and UF Innovate | Sid Martin Biotech graduate Oragenics, Inc., a leader in the development of new antibiotics against infectious diseases and effective treatments for oral mucositis, announces that the stabilized pre-fusion spike protein trimer produced by its Canadian collaborator and licensed by the company from the National Institutes of Health (NIH) generates neutralizing antibodies in mice after immunization against SARS-CoV-2, when administered with several novel intramuscular (IM) and intranasal (IN) adjuvants.

Two-Year Backlog in Biologicals Manufacturing Hinders Medical R&D, Development of New Therapies for COVID-19

One area where COVID-19 has had a substantial impact is the development and manufacturing of medicines, medical devices, and pharmaceutical products. The CDMO industry is showing enormous growth and is projected to become a $315 billion industry by 2026. However, the demand for products skyrocketed so quickly that supply has not been able to keep pace. According to Dr. Ian White, president and CSO of Neobiosis, a UF Innovate | Sid Martin Biotech resident company that focuses on the science of regenerative medicine, demand has caused a two-year backlog of desperately needed cellular and acellular products for use in research and clinical trials directed at treating the COVID-19 virus and its complications (AKA Post-COVID Syndrome).